<html>

        <head>
        <link href="../style1.css" rel="stylesheet" type="text/css">
        </head>
        <table border = 1>
        <tr>
        <th>PubMedID</th>
        <th>Sentence</th>
        <th>First Gene</th>
        <th>Second Gene</th>
        <th>Interaction</th>
        </tr>
        <body>
<tr class = "cellcolor">
<td>24276590</td>
<td>The purpose of this study was to examine TGF-β1, SNAI1 and MMP-9 expression in papillary thyroid carcinoma (PTC), and to assess association of TGF-β1, SNAI1 and MMP-9 expression with several clinicopathological indicators of PTC</td>
<td>SNAI1</td>
<td>PTC</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24276590</td>
<td>The mRNA expression levels of TGF-β1, SNAI1 and MMP-9 in 12 fresh PTC specimens with lymph node metastasis (LNM), 12 fresh PTC specimens without LNM and their matched normal thyroid specimens were assessed by real-time RT-PCR</td>
<td>SNAI1</td>
<td>PTC</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24276590</td>
<td>Collectively, the present results indicate that immunohistochemical and real-time RT-PCR evaluation of TGF-β1, SNAI1 and MMP-9 expression in PTC may be useful to predict the risk of LNM in PTC patients.</td>
<td>SNAI1</td>
<td>PTC</td>
<td>None</td>
</tr>
